The Kidney Transplant Market was valued at USD 8.68 billion in 2023 and is expected to reach USD 16.03 billion by 2032, growing at a CAGR of 7.07% over the forecast period of 2024-2032. This report identifies donor trends, comparing living and deceased donation between regions, based on cultural, medical, and regulatory considerations. The research examines transplant waiting lists and organ availability, with a focus on the continued mismatch between demand and supply that fuels the need for organ preservation technologies and alternative treatment options. Further, it reviews cost and reimbursement trends and illustrates regional differences in healthcare coverage, insurance programs, and financial aid schemes affecting patient access to transplantation. It also reviews post-transplant results and survival, examining innovations in immunosuppressive drugs, targeted therapy, and post-op care, improving long-term success rates.
The U.S. Kidney Transplant Market was valued at USD 2.82 billion in 2023 and is expected to reach USD 4.76 billion by 2032, growing at a CAGR of 6% over the forecast period of 2024-2032. In the United States, the kidney transplant market is growing because of government initiatives, increasing organ donation awareness programs, and policy changes that seek to enhance reimbursement models and decrease transplant waiting times.
Drivers
Advancements in Transplant Techniques, Rising ESRD Cases, and Improved Organ Preservation Methods
The kidney transplantation market is fueled by the growing number of cases for end-stage renal disease (ESRD) and more than 850 million individuals across the globe living with chronic kidney diseases (CKD), creating a boom for transplant need. Improvements in transplant procedures, including robotic-assisted kidney transplants and minimally invasive donor nephrectomy, have resulted in advanced surgical results and improved patient recovery. In addition, advances in organ preservation techniques, such as normothermic machine perfusion (NMP), have prolonged donor kidney viability, lowering delayed graft function and rejection rates. Rising knowledge and public perception, along with government campaigns to encourage organ donation, e.g., Spain's record-breaking organ donation program with more than 48 donors per million population, have boosted transplant volumes. Moreover, progress in immunosuppressive drugs has enhanced graft survival, leading to higher post-transplant quality of life. The growing prevalence of paired and altruistic kidney donation programs is also propelling transplant volumes, overcoming compatibility problems, and shortening waiting periods.
Restraints
Shortage of Donor Organs, High Cost of Transplantation, and Ethical Concerns
Even with increasing demand for transplants, a severe shortage of donor kidneys is a key limitation, with more than 100,000 patients listed for kidney transplants in the U.S. but only approximately 25,000 transplants done per year. The expense of kidney transplantation, including surgery, post-transplant immunosuppressive drugs, and ongoing monitoring, is a limiting factor, especially among poor communities. A kidney transplant may cost as much as USD 400,000 in the United States, and it is, therefore, a financial burden for uninsured and underinsured patients. Ethical issues of organ trafficking and the sale of living donors are ongoing challenges of the market, with the illegal trade of organs accounting for 10% of all transplants globally, based on an assessment by the World Health Organization (WHO). Also, inequalities in access to transplantation, which are driven by socioeconomic status and racial disparities, hold the market back.
Opportunities
Emerging Xenotransplantation, Artificial Kidney Research, and Increasing Public-Private Partnerships
Xenotransplantation developments, such as recent pig-to-human kidney transplant successes, offer enormous opportunities in terms of solving the shortage of donor organs. Development in bioartificial kidneys, such as the Kidney Project's implantable artificial kidney, offers prospects to transform the treatment of kidney failure without donors. The growing use of blockchain and AI-based organ allocation platforms is increasing transparency and efficiency in matching donors and recipients, cutting waiting times. Also, increasing partnerships between governments and private agencies to finance kidney transplant programs is increasing access. For instance, the U.S. Advancing American Kidney Health Initiative is funding research aimed at enhancing transplantation rates and other therapies. More donations are being spurred by heightened public awareness campaigns and financial incentives for living donors, such as tax deductions and paid medical leave.
Challenges
Risk of Organ Rejection, Post-Transplant Complications, and Long-Term Immunosuppressant Dependency
One of the most significant challenges in kidney transplant is organ rejection, with acute rejection in 10-15% of the recipients within the first year. Although there has been progression in immunosuppressive therapy, long-term immunosuppressive drug exposure raises the risk of infections, cardiovascular diseases, and cancer. Transplant recipients also need lifelong immunosuppressant drugs, which may cost more than USD 10,000 per year, so long-term management is costly. Complications that occur post-transplantation, such as graft-versus-host disease (GVHD), delayed graft function (DGF), and nephrotoxicity, endanger patient outcomes and also contribute to a rise in hospitalization rates. Lack of adequately trained transplant surgeons and specialty transplant centers within developing countries also denies access to proper care, introducing inequalities into treatment access.
By Type
The deceased donor kidney transplant segment was the market leader with the highest revenue share at 69.8% in 2023. This leadership is mainly due to the growing supply of organs from brain-dead donors and the established infrastructure for deceased donor organ procurement and allocation. Moreover, improvements in organ preservation methods and government policies encouraging deceased organ donation have also contributed to the dominance of the segment.
The living donor transplant segment is also expected to grow at the fastest rate throughout the forecast period. The reasons include the growing popularity of minimally invasive donor nephrectomy methods, decreased wait times than for deceased donor transplants, and enhanced awareness for paired and altruistic kidney donation programs. Further, increased post-transplant survival rates and mounting support to living donors with monetary aid and health policies are propelling the segment's growth.
By Preservation Method
The static cold storage (SCS) segment dominated the market with a 42.6% share in 2023. Its popularity is attributed to its affordability, ubiquitous availability, and simplicity of use in maintaining donor kidneys. SCS has continued to be the gold standard technique for kidney preservation, especially in areas with limited access to sophisticated perfusion technologies. The technique's capacity to efficiently suppress metabolic activity and prolong organ viability has guaranteed its continued use in transplant centers across the globe.
Normothermic machine perfusion (NMP) is expected to increase at the highest rate over the next few years. The reason behind its growth is its potential to increase organ viability through continuous oxygen and nutrient supply, minimizing ischemic damage and enhancing post-transplant survival. The rise in the adoption of NMP is also bolstered by continuing clinical trials that have proven its efficiency in lowering delayed graft function and increasing the donor pool by using marginal kidneys.
North America led the kidney transplant market in 2023 with established health infrastructure, a high rate of organ donation, and improved transplant methods. The United States alone conducts more than 25,000 kidney transplants every year, with the government actively promoting organ donation by implementing programs such as the National Organ Transplant Act (NOTA) and the Advancing American Kidney Health Initiative. The availability of new organ preservation technologies, including normothermic machine perfusion (NMP), further solidifies the region's market leadership. Favorable reimbursement policies and the presence of leading transplant centers are also fueling growth.
The European kidney transplant market is expected to grow at the highest rate in the forecast period, propelled by rising rates of organ donations and technological developments in transplants. Spain is the global organ donation leader, with more than 48 donors per million population, thanks to its extremely efficient organ procurement system. Germany, France, and the UK are also experiencing an increase in living and deceased donor transplants through government-initiated awareness campaigns and better donor registry systems. Advances in technology, such as machine perfusion methods and robotic-assisted transplants, are improving success rates and minimizing transplant rejection rates. Furthermore, positive health policies and transfrontier organ exchange schemes, including the Eurotransplant system, are enhancing transplant availability, such that Europe is the fastest-developing area of the kidney transplant market.
Paragonix Technologies – KidneyVault Portable Renal Perfusion System
Organ Recovery Systems – LifePort Kidney Transporter
XVIVO Perfusion AB – Kidney Assist Transport
Organ Assist B.V. – Kidney Assist
TransMedics, Inc. – Organ Care System (OCS) Kidney
OrganOx Limited – Metra Normothermic Perfusion System
Bridge to Life Ltd – LifeCradle Heart Preservation Transport System
Waters Medical Systems – RM3 Renal Preservation System
Organ Transport Systems – LifePort Kidney Transporter
CareDx – AlloSure Kidney
In April 2025, Massachusetts General Hospital (MGH) successfully performed its second pig kidney transplant in a living human, nearly a year after the first. Meanwhile, the US FDA has approved clinical trials, marking a significant advancement in xenotransplantation.
In April 2025, Vanderbilt Health successfully performed its first kidney transplant using the Paragonix KidneyVault Renal Perfusion System, an FDA-cleared organ preservation technology. This makes Vanderbilt the first in Tennessee and among the first in the Southeast to adopt this innovative system for kidney transport.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 8.68 billion |
| Market Size by 2032 | USD 16.03 billion |
| CAGR | CAGR of 7.07% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type [Living Donor Transplants, Deceased Donor Transplants (Donation after Brain Death (DBD), Donation after Circulatory Death (DCD)] • By Preservation Method [Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP), Normothermic Machine Perfusion (NMP)] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Paragonix Technologies, Organ Recovery Systems, XVIVO Perfusion AB, Organ Assist B.V., TransMedics, Inc., OrganOx Limited, Bridge to Life Ltd, Waters Medical Systems, Organ Transport Systems, and CareDx. |
Ans: The Kidney Transplant Market is projected to grow at a CAGR of 7.07% during the forecast period.
Ans: By 2032, the Kidney Transplant Market is expected to reach USD 16.03 billion, up from USD 8.68 billion in 2023.
Ans: Advancements in Transplant Techniques, Rising ESRD Cases, and Improved Organ Preservation Methods.
Ans: Shortage of Donor Organs, High Cost of Transplantation, and Ethical Concerns are the growth hindrances for the kidney transplant market.
Ans: North America is the dominant region in the Kidney Transplant Market.
Table of contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Donor Trends (Living vs. Deceased), by Region (2023)
5.2 Transplant Waiting List and Organ Availability (2023)
5.3 Cost and Reimbursement Trends, by Region (2023)
5.4 Post-Transplant Outcomes and Survival Rates (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Kidney Transplant Market Segmentation, by Type
7.1 Chapter Overview
7.2 Living Donor Transplants
7.2.1 Living Donor Transplants Market Trends Analysis (2020-2032)
7.2.2 Living Donor Transplants Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Deceased Donor Transplants
7.3.1 Deceased Donor Transplants Market Trends Analysis (2020-2032)
7.3.2 Deceased Donor Transplants Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Donation after Brain Death (DBD)
7.3.3.1 Donation after Brain Death (DBD) Market Trends Analysis (2020-2032)
7.3.3.2 Donation after Brain Death (DBD) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Donation after Circulatory Death (DCD)
7.3.4.1 Donation after Circulatory Death (DCD) Market Trends Analysis (2020-2032)
7.3.4.2 Donation after Circulatory Death (DCD) Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Kidney Transplant Market Segmentation, by Preservation Method
8.2 Static Cold Storage (SCS)
8.2.1 Static Cold Storage (SCS) Market Trends Analysis (2020-2032)
8.2.2 Static Cold Storage (SCS) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Hypothermic Machine Perfusion (HMP)
8.3.1 Hypothermic Machine Perfusion (HMP) Market Trends Analysis (2020-2032)
8.3.2 Hypothermic Machine Perfusion (HMP) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Normothermic Machine Perfusion (NMP)
8.4.1 Normothermic Machine Perfusion (NMP) Market Trends Analysis (2020-2032)
8.4.2 Normothermic Machine Perfusion (NMP) Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.4 North America Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.5.2 USA Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.6.2 Canada Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.6.2 France Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 China Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 India Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 Japan Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.9.2 Australia Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.4 Africa Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Kidney Transplant Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.4 Latin America Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Kidney Transplant Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Kidney Transplant Market Estimates and Forecasts, by Preservation Method (2020-2032) (USD Billion)
10. Company Profiles
10.1 Paragonix Technologies
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Organ Recovery Systems
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 XVIVO Perfusion AB
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Organ Assist B.V.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 TransMedics, Inc.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 OrganOx Limited
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Bridge to Life Ltd
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Waters Medical Systems
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Organ Transport Systems
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 CareDx
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Living Donor Transplants
Deceased Donor Transplants
Donation after Brain Death (DBD)
Donation after Circulatory Death (DCD)
By Preservation Method
Static Cold Storage (SCS)
Hypothermic Machine Perfusion (HMP)
Normothermic Machine Perfusion (NMP)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Bed head panel Market was valued at USD 2.92 billion in 2023 and is expected to reach USD 3.88 billion by 2032, growing at a CAGR of 3.23% over the forecast period of 2024-2032.
The Biodegradable Medical Plastics Market Size was valued at USD 1.7 Bn in 2023 and will reach USD 4.5 Bn by 2032 and grow at a CAGR of 11.5% Over the Forecast Period of 2024-2032.
The Digestive Health Supplements Market Size was valued at USD 51.65 Billion in 2023 and is expected to reach USD 111.96 Billion by 2032 and grow at a CAGR of 9.42% over the forecast period 2024-2032.
Cell Viability Assay Market was valued at USD 1.69 billion in 2023 and is expected to reach USD 3.77 billion by 2032, growing at a CAGR of 9.22% from 2024-2032.
The Personalized Retail Nutrition and Wellness Market size was estimated at USD 3.45 billion in 2023 and is projected to reach USD 12.58 billion by 2032.
Micro Syringes Market was valued at USD 333.98 million in 2023 and is expected to reach USD 1422.12 million by 2032, growing at a CAGR of 17.48% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
